Meeting
2016 ASCO Quality Care Symposium
Real-world treatment patterns and health care resource utilization (HRU) among patients with chronic lymphocytic leukemia (CLL) by regimen.
Authors
Brad Schenkel
Janssen Scientific Affairs, LLC, Horsham, PA
Brad Schenkel, Lorie Ellis, Stephanie Korrer, Stacey DaCosta Byfield
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Practice of Quality and Cost, Value, and Policy in Quality
Track
Cost, Value, and Policy in Quality,Practice of Quality,Science of Quality
Sub Track
Measuring Value and Costs
Citation
J Clin Oncol 34, 2016 (suppl 7S; abstr 15)
DOI
10.1200/jco.2016.34.7_suppl.15
Abstract #
15
Poster Bd #
B12
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Quality Care Symposium
What are the health care costs for chronic lymphocytic leukemia?
First Author: Matthew J. Matasar
Poster
2014 ASCO Annual Meeting
Treatment patterns, mortality, and costs of care in unfit patients (pts) with relapsed chronic lymphocytic leukemia (CLL).
First Author: Helen Varker
Poster
2016 ASCO Quality Care Symposium
Real-world treatment patterns, health care resource utilization (HRU), and costs among patients with Waldenstrom macroglobulinemia (WM) initiating therapy.
First Author: Brad Schenkel
Poster
2023 ASCO Annual Meeting
BELLWAVE-008: A phase 3 study of the efficacy and safety of nemtabrutinib in previously untreated patients (pts) with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) without TP53 aberrations.
First Author: Ömür Gökmen Sevindik